NIOSH Exploratory/Developmental Grant Program (R21)
ID: 305594Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $200K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/305594

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-18-798.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted May 24, 2018, 12:00 AM UTC
  4. 4
    Due Nov 17, 2024, 12:00 AM UTC
Description

The Centers for Disease Control and Prevention (CDC) is offering the NIOSH Exploratory/Developmental Grant Program (R21) to support innovative research aimed at understanding and mitigating risks associated with occupational diseases and injuries. This grant program encourages applicants to develop projects that identify hazardous working conditions, create preventive measures, and translate scientific findings into effective workplace practices, aligning with the strategic goals of the National Occupational Research Agenda (NORA). The program emphasizes collaboration and the dissemination of research findings, with a total estimated funding of $1 million and an award ceiling of $200,000 for individual projects over a two-year period. Interested applicants must submit their proposals by November 17, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further assistance.

Point(s) of Contact
FBOWebmaster@OD.NIH.GOV
Files
Title
Posted
PAR-18-798.html
Aug 24, 2024, 2:22 AM UTC
The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), has issued the NIOSH Exploratory/Developmental Grant Program (R21) Funding Opportunity Announcement (FOA) aimed at advancing research in occupational safety and health. This program is intended to support innovative projects that identify risks associated with occupational diseases and injuries, develop preventive measures, and translate findings into effective workplace practices. Key objectives include identifying hazardous working conditions, creating new protective technologies, and assessing the economic impacts of occupational health issues. The FOA encourages diverse applicants, including educational institutions and nonprofit organizations, to explore novel research approaches while addressing specific burdens in occupational health. Successful applications should align with the strategic goals of NIOSH, particularly in light of the National Occupational Research Agenda (NORA). The funding allows up to $275,000 in direct costs over a two-year period, with an emphasis on collaboration and effective dissemination of research findings. The program underlines the importance of scientific innovation to reduce worker exposure to hazards and improve overall public health outcomes.
Similar Opportunities
NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
Centers for Disease Control and Prevention - ERA
The Centers for Disease Control and Prevention (CDC) is offering a grant opportunity titled "NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)" aimed at supporting high-quality scientific meetings that advance research in occupational safety and health. Eligible applicants, including nonprofits without 501(c)(3) status and higher education institutions, are encouraged to submit proposals that align with NIOSH's strategic goals and the National Occupational Research Agenda (NORA), focusing on significant occupational health issues. This initiative underscores NIOSH's commitment to enhancing workplace safety through rigorous research and collaboration among experts, with a total funding amount of $500,000 available for up to five awards, each ranging from $10,000 to $20,000. Interested parties should submit their applications by December 15, 2025, and can contact Sharon Chou, Ph.D., at SChiou@cdc.gov for further information.
National Center for Construction Safety and Health Research and Translation (U54)
Centers for Disease Control and Prevention - ERA
The Centers for Disease Control and Prevention (CDC) is inviting applications for the National Center for Construction Safety and Health Research and Translation (U54), aimed at reducing work-related injuries and illnesses in the construction industry. This funding opportunity encourages multidisciplinary research and intervention strategies that focus on hazard identification, the development of safety practices, and the dissemination of best practices to enhance the health and safety of U.S. construction workers. The initiative aligns with national public health goals, including the Healthy People 2030 objectives, and emphasizes collaboration with various stakeholders to address significant health burdens in the construction workforce. The total funding available is approximately $28.75 million over five years, with individual awards capped at $5.75 million per budget year. Interested applicants must submit a Letter of Intent by November 1, 2023, and complete applications by December 1, 2023, with subsequent deadlines on October 31 in the following years until 2026. For further inquiries, applicants can contact Sharon Chiou at 304-285-6029 or via email at schiou@cdc.gov.
State Occupational Safety and Health Surveillance Program (U60)
Centers for Disease Control and Prevention - ERA
The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for the State Occupational Safety and Health Surveillance Program (U60), aimed at enhancing state-level surveillance of workplace safety and health issues. This cooperative agreement seeks to assess the extent of workplace illnesses, injuries, and fatalities, identify high-risk occupations, and develop effective prevention strategies through a network of partnerships and data-driven initiatives. With an estimated total program funding of $40 million and an award ceiling of $705,000, the CDC anticipates making approximately 23 awards, with applications due by September 30, 2025. Interested applicants can reach out to Dr. Eduardo O'Neill at 404-718-8844 or via email at fzt4@cdc.gov for further information.
Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
Centers for Disease Control and Prevention - ERA
The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity through the Commercial Fishing Occupational Safety Research Cooperative Agreement (U01) aimed at enhancing the safety of workers in the commercial fishing industry. This initiative seeks to support research that addresses various aspects of occupational safety, including vessel design improvements, emergency equipment development, and enhanced monitoring systems, targeting entities with expertise in fishing and maritime safety. With an estimated total program funding of $3 million and awards ranging from $150,000 to $975,000, the CDC anticipates making approximately 20 awards. Interested applicants must submit their proposals electronically by 5:00 PM ET on January 31, 2028, and can direct inquiries to Bridgette Garrett at bgarrett@cdc.gov.
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH), through the National Institute for Occupational Safety and Health (NIOSH), is offering funding opportunities for conferences and scientific meetings aimed at promoting occupational safety and health. The initiative seeks to support high-quality gatherings that advance research and address priority areas in the field of occupational health, with applications invited under the U13 funding mechanism, which facilitates cooperative agreements involving significant federal staff engagement. Up to four awards may be granted annually, with a total funding allocation of $600,000 over five years, allowing for individual conference funding of up to $30,000, extendable to $75,000 with prior approval. Interested applicants, including educational institutions and nonprofits, must ensure their proposals align with NIOSH’s strategic goals and address health disparities, with applications due by December 14, 2025. For further details, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the funding announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-21-193.html.
Assessment and Evaluation of Emerging Health Conditions Relevant to the World Trade Center Health Program (U01)
Centers for Disease Control and Prevention - ERA
The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Assessment and Evaluation of Emerging Health Conditions Relevant to the World Trade Center Health Program (U01)." This cooperative agreement aims to support research projects that investigate health conditions potentially related to the September 11, 2001, terrorist attacks, focusing on diagnosing and treating conditions that have emerged since the establishment of the WTC Health Program. The initiative is particularly interested in interdisciplinary collaborations that address health equity and the health burdens faced by vulnerable populations exposed to the 9/11 attacks. The estimated total program funding is $33 million, with an award ceiling of $550,000 and approximately 20 awards expected. Interested applicants can reach out to Dr. James Yiin at JYiin@cdc.gov or by phone at 513-841-4271, with applications due by October 28, 2025, and awards anticipated by June 26, 2026.
RFA-DD-18-000
Centers for Disease Control and Prevention - ERA
The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-DD-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program expected to award approximately 10 grants. This funding is crucial for enhancing public health efforts, although specific funding amounts have not been disclosed. Interested parties should submit their applications by October 13, 2025, and can direct inquiries to Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering a funding opportunity titled "NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)" aimed at supporting innovative preclinical and early-phase clinical research in cancer diagnosis, treatment, and prevention. This grant, with a funding ceiling of $275,000 over two years, encourages exploratory studies that may involve significant risk but have the potential to lead to breakthroughs in cancer research, particularly for underserved populations. Applications will be evaluated based on their significance, innovation, and rigor, with key deadlines for submission set for January 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.